BG-C0902
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BG-C0902, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors [Phase 1]